Bacterin International is expanding into Europe and has allied with a distributor to help execute its plan. The Montana developer of bone graft materials and medical coatings said it would work with DMP Spine Biologics to distribute its products throughout the European Union. Bacterin CEO Daniel Goldberger said in a statement that the deal gives his company access to DMP's "extensive relationships throughout Europe" as well as the distributor's knowledge of various orthopedic and spine markets. DMP has long distributed U.S. orthopedic and spine products in Europe, the Middle East and elsewhere. Item